Observations placeholder
Zytiga
Identifier
020478
Type of Spiritual Experience
Number of hallucinations: 11
Background
A description of the experience
Abiraterone acetate (INN, USAN, BAN, JAN) (brand names Zytiga, Abiratas, Abretone, Abirapro) is a steroidal antiandrogen, specifically an androgen synthesis inhibitor, used in combination with prednisone in metastatic castration-resistant prostate cancer (formerly hormone-resistant or hormone-refractory prostate cancer) – i.e., prostate cancer not responding to androgen deprivation or treatment with androgen receptor antagonists. It is a prodrug to the active agent abiraterone, and is marketed under the trade name Zytiga.
Adverse effects
Adverse effects by frequency:very common (>10% frequency):
- Urinary tract infection
- Hypokalemia
- Hypertension
- Diarrhoea
- Peripheral edema
Common (1-10% frequency):
- Hypertriglyceridaemia
- Sepsis
- Cardiac failure
- Angina pectoris
- Arrhythmia
- Atrial fibrillation
- Tachycardia
- Dyspepsia (indigestion)
- Rash
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Fractures
- Hematuria
Uncommon (0.1-1% frequency):
- Adrenal insufficiency
- Myopathy
- Rhabdomyolysis
Rare (<0.1% frequency):
- Allergic alveolitis
On Dec, 25, 2016 6,388 people reported to have side effects when taking Zytiga.
Among them, 11 people (0.17%) have Hallucination
On Feb, 6, 2016: 781 people reported to have side effects when taking Zytiga. Among them, 53 people (6.79%) have Death.
Time on Zytiga when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 43.75% | 37.50% | 18.75% | 0.00% | 0.00% | 0.00% | 0.00% |